Mark J Alles
CIK 1538897 · CEO, CHAIRMAN OF BOARD · last filed 2023-09-19
Mark J Alles is a CEO, CHAIRMAN OF BOARD who has filed 71 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for SYRS, was dated Sep 19, 2023. Across all open-market trades the lifetime net is −$28.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $844.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$844.6K
4
71
-$28.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRS | Director | 3,666 | $0.00 | $1 | $88.6K | 8 | 2023-09-19 |
| BMRN | Director | 15,095 | $55.95 | $844.6K | $314.5K | 4 | 2023-05-24 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | Director | 0 | $76.01 | $0 | $162.7K | 4 | 2022-08-17 |
| CELGENE CORP /DE/ (CELGZ) Delisted | CEO, CHAIRMAN OF BOARD | 292,081 | — | — | -$28.64M | 55 | 2019-11-22 |
Recent Filings
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-19 | SYRS | Exer (M) | +2,666 | $0 | EDGAR |
| 2023-06-02 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2023-05-24 | BMRN | Grant (A) | +4,190 | $0 | EDGAR |
| 2022-11-02 | BMRN | Buy (P) | +3,625 | $314.5K | EDGAR |
| 2022-09-19 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2022-08-17 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Disp (D) | −2,000 | -$152.0K | EDGAR |
| 2022-06-02 | SYRS | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | BMRN | Grant (A) | +4,980 | $0 | EDGAR |
| 2022-01-05 | BMRN | Grant (A) | +2,300 | $0 | EDGAR |
| 2021-06-21 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Buy (P) | +2,000 | $162.7K | EDGAR |